Protocol for a Randomized, Open-Label Clinical Trial on the Effect of Mouthwash on Salivary SARS-CoV-2 Load
Authors:
- Keiji KonishiKKKeiji Konishi
- Daisuke OnozukaDODaisuke Onozuka
- Satoko TakateraSTSatoko Takatera
- Hiroo MatsuoHMHiroo Matsuo
- Hisao YoshidaHYHisao Yoshida
- Shigeto HamaguchiSHShigeto Hamaguchi
- Shungo YamamotoSYShungo Yamamoto
- Ryuichi Minoda SadaRSRyuichi Minoda Sada
- Koichiro SuzukiKSKoichiro Suzuki
- Satoshi KutsunaSKSatoshi Kutsuna
Open Access
Abstract
Mouthwashes containing cetylpyridinium chloride (CPC) or on-demand aqueous chlorine dioxide (ACD) have potential to reduce the salivary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load in individuals with SARS-CoV-2 infection. This study will evaluate the effect of CPC and on-demand ACD mouthwashes on salivary SARS-CoV-2 levels in individuals with acute asymptomatic or mild SARS-CoV-2 infection (COVID-19) staying in a residential recuperation facility in Osaka, Japan. This randomized, open-label clinical trial will include three equal-sized groups (CPC mouthwash, on-demand ACD mouthwash, and placebo), with 30 participants per group. A stratified replacement block method will be used to ensure balanced allocation based on symptom presence and days since symptom onset. Participants will use mouthwash at set times for 7 days or until the end of recuperation. Saliva samples will be collected at multiple time points and tested for SARS-CoV-2 using quantitative reverse transcription polymerase chain reaction. The primary outcome will be changes in salivary SARS-CoV-2 viral load 2 h after the first mouthwash use compared with the pre-mouthwash level. Secondary outcomes will include changes in salivary viral load and clinical parameters at different time points. This study was registered with the Japan Registry of Clinical Trials on 18 October 2022 (jRCTs051220107).Keywords
Funding Information
- Earth Corporation, Tokyo, Japan
This publication has 10 references indexed in Scilit:
- First drug-checking study at an electronic festival and fentanyl detection in the central region of MexicoHarm Reduction Journal, 2023
- Electrolyzed water for the microbiologic control in the pandemic dental setting: a systematic reviewBMC Oral Health, 2022
- Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2Scientific Reports, 2022
- CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human salivaJournal of Medical Microbiology, 2022
- Chlorine dioxide is a more potent antiviral agent against SARS-CoV-2 than sodium hypochloriteJournal of Hospital Infection, 2021
- Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In VitroJournal of Dental Research, 2021
- Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trialHeliyon, 2021
- Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in SingaporeInfection, 2020
- The Respiratory Chain of Bacteria is a Target of the Disinfectant MA-TBPB Reports, 2020
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsBMJ, 2013